Update on the treatment of childhood-onset systemic lupus erythematosus
10.3760/cma.j.cn101070-20200217-00170
- VernacularTitle:儿童系统性红斑狼疮治疗进展
- Author:
Yue ZENG
;
Yubin WU
- From:
Chinese Journal of Applied Clinical Pediatrics
2021;36(10):797-800
- CountryChina
- Language:Chinese
-
Abstract:
Systemic lupus erythematosus (SLE) is a serious multisystem autoimmune disease with different clinical manifestations.Childhood-onset SLE (cSLE) is similar to adult-onset SLE, while its morbidity and mortality are higher than adults, and it is prone to damage important organs.Therefore, early diagnosis and treatment are very important.With the in-depth exploration of the pathogenesis and the development of cell and molecular biology, the progress of drug therapy for SLE has been promoted.Immunosuppression still remains the cornerstone of treatment, and glucocorticoids still plays a leading role.Biologics bring the gospel to SLE patients, and non-specific immunotherapy gains treatment time for refractory and severe SLE patients.Treatment options are led by the level of disease severity.It is of great significance to understand the treatment progress of cSLE and combine theory with practice together to control the disease activity and improve the prognosis.This article reviews recent advances regarding the update on the treatment of cSLE in recent years.
